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Abstract: The phycobilin pigments are intensively fluorescent and water soluble. They are categorized into three 
types, such as pigments containing high, intermediate and low energies are phycoerythrins (phycoerythrocyanins), 
phycocyanins and allophycocyanins, respectively. Besides light harvesting, the phycobiliproteins have shown 
industrial and biomedical importance. Among them, C-phycocyanin (C-PC) has been considered to be the most 
preferred one. The present study was undertaken to evaluate the antimalarial activity of C-PC isolated from a 
nitrogen-fixing cyanobacterium and Nostoc muscorum. C-PC was extracted and purified by acetone extraction and 
ammonium sulfate precipitation and dialysis followed by amicon filtration. It was isolated as a~124 kDa water 
soluble protein molecule. It showed antimalarial activity in vitro against chloroquine sensitive and resistant 
Plasmodium falciparum strains. Inhibitory concentrations at 50%, 90% and 95% were determined as 10.27±2.79, 
53.53±6.26 and 73.78±6.92 µg/ml against the chloroquine-sensitive strains; 10.37±1.43, 56.99±11.07 and 
72.79±8.59 µg/ml against chloroquine resistant of Plasmodium falciparum strains. C-PC was found to have 
antimalarial activity even at a concentration of 3.0µg/ml. The possible mechanism might be relied on the destruction 
of polymerization of haemozoin by binding of C-PC with ferriprotoporphyrin-IX at the water surface of the plasma 
membrane. 
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1. Introduction 
 
Malaria remains a major public health problem 
resulting into an unacceptable toll on the health and 
economic welfare of the world’s poor communities. 
Over 200–500 million cases and 0.7–2.7 million deaths 
occur each year due to malaria and making it one of the 
top three killers among communicable diseases [1]. 
Among Southeast Asian countries, India alone 
contributes more than 80% malaria cases and 
Plasmodium falciparum accounts for 35-40% cases [2]. 
Despite intensive efforts to control malaria, the disease 
continues to be one of the greatest health problems in 
Indian sub-continent. 
Although a number of advances have been made 
towards the understanding of the disease, relatively few 
antimalarial drugs have been developed in the last 30 
years [3]. For the treatment and control of malaria 
depends largely on a limited number of 
chemoprophylactic and chemotherapeutic agents, there 
is an urgent need to develop novel, affordable 
antimalarial treatments. The development of safe and 
effective antimalarial agents has been realized as a 
challenge in recent years because of the rapid spread of 
drug resistant P. falciparum strains. Over the years 
chloroquine has been used as a safe, effective and 
readily available anti-malarial drug. The mechanism of 
chloroquine resistance in Plasmodium was first reported 
about two decades back and presently it is found by 
many users that chloroquine is no longer effective in 
most of the endemic areas as because of P. falciparum 
has developed resistance to it [4, 5]. 
Historically, the majority of antimalarial drugs has 
been derived from medicinal plants or from structures 
modelled on plant lead compounds. These include the 
quinoline-based antimalarials as well as artemisinin and 
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its derivatives [6]. Indian subcontinent boasts 
remarkably for its biodiversity and rich cultural 
traditions of plant use. Scientific understanding of 
medicinal plants is, however, largely unexplored and 
pharmacological investigation of the Indian flora only 
gained momentum recently [7]. 
Cyanobacteria are valuable organisms that 
contribute significantly to the total carbon biomass and 
primary productivity [8]. In cyanobacteria, the light-
harvesting pigments are chlorophyll-a, carotenoids and 
phycobiliproteins. Phycobiliproteins are a family of 
hydrophilic, brilliantly coloured and stable fluorescent 
pigment proteins (Fig. 1) covalently linked with a linear 
tetrapyrrole prosthetic group (bilins) that, in their 
functional state, are covalently linked to specific 
cysteine residues of the proteins [9]. These intensely 
coloured proteins are occurring in Cyanophyceae, 
Rhodophyceae and Cryptophyceae. They are 
subdivided into three main groups according to their 
structural property, as phycocyanin (blue), 
allophycocyanin (blue) and phycoerythrin (red). Where 
phycocyanin and allophycocyanin are always present in 
Cyanophyceae and Rhodophyceae but phycoerythrin 
may be absent in the former [10]. The energy transfer 
occurs from phycocyanin to allophycocyanin to 
Chlorophyll-a (in the case of Cyanobacteria). The 
absorption maximum for C-phycocyanin is 620nm. 
Because of unique colour, proteinous nature, 
fluorescent and antioxidant properties, a wide range of 
promising applications of phycobiliproteins in 
diagnostics, biomedical research and therapeutics are 
possible [11]. 
 
 
 
Fig. 1. Chemical structure of C-phycocyanin. 
 
In the present study, we have isolated C-
phycocyanin from nitrogen fixing cyanobacterium, 
Nostoc muscorum. It was purified and characterized. 
We have made an attempt to study the antimalarial 
activity of C-phycocyanin and its inhibitory effect on P. 
falciparum culture was described. C-phycocyanin has 
not been reported so far for its antiplasmodial activity. 
 
2. Materials and Methods 
 
2.1 Algal material, culture, extraction and 
purification of C-phycocyanin 
Nostoc muscorum was cultured in BG-11 medium 
without any combined nitrogen sources at pH 8.0 [12]. 
The culture was done in conical flasks and maintained 
at temperature 25±2°C with light intensity of              
75µM m-2 s-1 PAR at the light: dark cycles of 14:10 h 
and dry cell weight (DCW) was determined 
gravimetrically. 
The C-phycocyanin (C-PC) was obtained by 
acetone extraction. Briefly, cell suspension of Nostoc 
muscorum was centrifuged at 5000 rpm for 10 min. The 
cell pellet was mixed well with 20ml of 80% acetone 
and incubated overnight at 4°C. After centrifugation, 
the pellet was mixed with 20 ml of sterile distilled 
water and kept at 50°C for 30 min. The suspension was 
centrifuged and the supernatant was stored as a crude 
extract of phycobiliproteins. 
The extract of crude phycobiliproteins was 
subjected to ammonium sulphate precipitation at 35%, 
40%, 45%, 50%, 60% and 70% saturation. Each 
precipitated fraction was dissolved in 1ml of 50mM 
Tris-buffer (pH 7.5) and dialysed. The optical density 
was measured at 280nm, 620nm and 650nm. The 
fraction with highest yield as per absorbance 620/280, 
i.e. 40% ammonium sulphate precipitate was taken for 
further work after concentrating by Amicon filtration 
with MW cut-off~30 kDa. 
The UV-Visual absorbance spectra (250-820nm) 
were recorded on UV-Vis Diode-Array 
spectrophotometer (Shimadzu, Columbia, MD, USA) as 
shown in Fig. 2. The amount and purity ratio of C-PC 
were calculated using the published equations as 
described elsewhere [13]. 
 
 
 
Fig. 2. Absorption spectrum of C-phycocyanin crude and after 40% ammonium sulphate fractionation. 
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2.2 Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Purified C-PC was put on polyacrylamide gel 
electrophoresis for molecular weight analysis on 
reducing and non-reducing gel. After electrophoresis, 
each lane of the gel was put separately for Coomassie 
brilliant blue and silver nitrate staining. The sizes of the 
resolved bands were determined by comparing with 
known molecular weight markers. 
 
2.3 Biological evaluation: Antimalarial activity in 
vitro 
Antimalarial activity was checked in six well-
adapted P. falciparum culture lines, 3 each for 
chloroquine sensitive (CQ-S) and chloroquine resistant 
(CQ-R) following the published method [14]. The 
parasite isolates were collected from different places of 
India from patients reported with symptomatic malaria. 
They were adapted and maintained in vitro by candle-
jar technique. Parasites were cultured in human O+ 
RBCs in RPMI 1640 media enriched with 10% (v/v) 
AB+ serum and supplemented with 25mM HEPES 
buffer and 25mM sodium bicarbonate. 
The assay was done in synchronous culture in the 
ring form at 5% hematocrit containing 1% parasitaemia 
in 96-well flat bottom tissue culture plate. C-PC was 
dosed at two-fold dilutions in wells in duplicate at 
concentrations ranging from 192–1.5μg/ml. 
The volume of culture in each well was kept 200μl 
including media, test sample, and parasite inoculum. 
Parasite culture only in enriched media was taken as 
controls. Chloroquine was used as reference 
antimalarial for comparison. To determine the activity 
of the compound, the assay was done in two sets. The 
first set was to determine the effect of compounds in 
schizont maturation after 24 h and the second set of 
assay was to determine the effect in total parasite 
growth after 48 h. Growth of the parasite from each 
well was monitored microscopically in Giemsa stained 
smears by counting number of schizonts per 200 
asexual parasites and total number of parasites per 5000 
RBCs. Percent schizont maturation inhibition and 
parasite growth inhibition were calculated by the 
formula;  
(1 – Nt / Nc) x 100 
 
Where, Nt and Nc represent the number of schizont 
or number of parasites in the test and control wells, 
respectively. Inhibitory concentrations at 50% (IC50), 
90% (IC90) and 95% (IC95) were calculated. 
 
3. Results and Discussion 
 
3.1 Extraction and purification of C-phycocyanin 
We have isolated crude phycobiliprotein from 
Nostoc muscorum and it was purified and further 
characterized. The concentration and purity of C-PC 
was increased on fractionation with ammonium 
sulphate. It was found to be maximum (3.25) in 40% 
ammonium sulphate fraction (Table 1). This simple step 
of purification yielded nearly 66% of C-PC is giving a 
final yield of 0.64mg/ml and 106.3mg/dcwg. Two sharp 
peaks were observed at 280nm and 620nm (Fig. 2). The 
purity and molecular weight of the sample obtained 
after 40% ammonium sulphate precipitation was 
confirmed using non-reducing and reducing PAGE 
(Fig. 3). Under non-reducing conditions, C-PC moved 
as a tight band of ~124 kDa suggesting it to be 
monomeric single population. Lane MW showed a 
molecular marker, while lanes NS and NC showed 
Silver nitrate and Coomassie brilliant blue staining of 
C-PC on non-reducing conditions. On reducing gel, C-
PC was resolved as seven polypeptides of molecular 
masses of ~17, ~19, ~33, ~42, ~47, ~50 and ~72 kDa, 
respectively (Lane R). 
 
 
 
Fig. 3. Polyacrylamide Gel Electrophoresis of C-phycocyanin. 
 
Lane MW - molecular weight marker; Lane R - reducing gel; Lane NS 
- Native PAGE stained with Silver nitrate, the band of C-PC showed 
greenish colour after staining; Lane NC - Native PAGE stained with 
Coomassie brilliant blue, the band of C-PC showed fluorescent 
bluish-violet colour after staining. 
 
Table 1. Extraction and partial purification of C-phycocyanin obtained by acetone extraction and by ammonium sulphate fractionation 
(Values are mean of three independent observations). 
 
Ammonium sulphate (%) A650 A620 A280 A620/A280 C-PC (mg/ml) C-PC (mg/dcwg) Recovery (%) 
0 0.28 0.91 0.92 0.99 0.97 166.7 - 
35 0.14 0.49 0.18 2.65 0.53 89.2 55.15 
40 0.15 0.57 0.17 3.25 0.64 106.3 65.75 
45 0.12 0.48 0.15 3.07 0.54 91.0 56.29 
50 0.14 0.51 0.18 2.85 0.56 93.8 58.04 
60 0.17 0.44 0.23 1.96 0.44 73.9 45.70 
70 0.11 0.38 0.15 1.48 0.41 69.3 42.88 
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Several methods of extraction and purification of 
C-PC have been described in published literature. 
Briefly, C-PC was extracted and purified from 
Aphanothece halophytica by using DNase, RNase and 
proteinase followed by ion exchange and gel 
permeation chromatography [15]. From crude extracts 
of Nostoc sp. (PCC 9202) C-PC was purified by 
ultrafiltration and ammonium sulphate precipitation 
followed by gel filtration and ion-exchange 
chromatography [16]. Another method for the optimum 
extraction and isolation of C-PC was described from the 
cyanobacterium Synechococcus sp. IO9201 (isolated 
from Caribbean waters) by freezing and thawing of the 
extract followed by and purification, hydrophobic 
interaction and ion exchange chromatography [17]. 
Purification of C-PC from Spirulina (Arthrospira 
fusiformis) was achieved by a multi-step treatment of 
the crude extract with rivanol followed by ammonium 
sulphate precipitation [18]. Extraction and purification 
of C-PC from Aphanizomenon flos-aquae was done by 
ultracentrifugation and hydrophobic chromatography 
using a hydroxyapatite column [19]. Most recently, 
extraction and purification of C-PC from Phormidium 
ceylanicum has been described by ultrafiltration [20]. 
Compared to all these procedures, the present method 
described in this study was easy and gave maximum 
recovery without using expensive chemicals and 
equipment. Thus it could be recommended as a simple 
and cost-effective extraction and purification method 
for C-PC from Nostoc muscorum. 
 
3.2 Effect of C-PC on Plasmodium falciparum 
growth 
The purified C-PC was tested in P. falciparum 
culture. Results obtained from the total parasite growth 
inhibition of both CQ-S and CQ-R strains are 
summarized in Table 2 and Fig. 4. Parasite count was 
done microscopically per 5000 RBCs after incubation 
of 24 h and 48 h with C-PC. Parasite count, 
multiplication rate, and parasite growth inhibition were 
calculated as described earlier [21]. Parasite growth was 
inhibited completely above the concentration of 
48μg/ml of C-PC. Figures 5-7 represent microscopical 
observation on the effect of C-PC in culture of P. 
falciparum at different time interval. Inhibitory 
concentrations of 50%, 90% and 95% were calculated 
in both CQ-S and CQ-R parasites by noting the parasite 
growth inhibition after 48 h (Table 3). 
 
 
 
Fig. 4. Growth inhibition of six P. falciparum isolates in the presence of C-phycocyanin after 48 hours. C-PC was dosed at two-fold dilutions in 
wells in duplicate at concentrations ranging from 192 – 1.5μg per well. Total parasite growth inhibition (PGI) of both chloroquine sensitive 
(Pf-1,2,3) and resistant (Pf-4,5,6) strains is shown. Parasite count was done microscopically and parasitaemia was calculated as the number 
of parasites per 5000 RBCs after incubation of 48 h with C-PC. Parasite growth inhibition (%) was calculated. 
 
Table 2. Effect of C-Phycocyanin in both chloroquine sensitive and chloroquine resistant Plasmodium falciparum culture lines. Parasite 
multiplication rate after 48 hours with or without C-phycocyanin (Values are mean of three independent observations). 
 
Parasite Count (PC) per 5000 RBCs 
(Multiplication Rate = No. of parasites at 48 h / No. of parasites at 0 h) 
Rows C-PC (µg/ml) Pf-1 Pf-2 Pf-3 Pf-4 Pf-5 Pf-6 
A 96 0 0 0 0 0 0 
B 48 0.25 0.5 0.4 0.57 0.5 0.4 
C 24 0.5 1 0.6 1 1 1 
D 12 0.87 1.63 1.4 1.43 1.33 1.6 
E 6 1.5 2.13 2.2 1.86 2.17 2.4 
F 3 2 2.75 3.4 2.57 3.17 3.4 
G 1.5 2.63 3.2 3.68 2.86 3.27 4 
H (Control) Without C-PC 2.5 3.12 3.6 3 3.33 4 
No. of parasites at ‘0’ hr. - 40 40 25 35 30 25 
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Fig. 5. Microscopic observations of C-PC addition to the in vitro culture of Plasmodium falciparum. 5. Culture after 24 h without C-PC is 
showing healthy schizont; Fig. 6. Culture after 24 h with C-PC is showing deformed schizont; Fig. 7. Culture after 48 h with C-PC, no further 
growth has observed. 
 
Table 3. Inhibitory concentrations 50%, 90% and 95% in P. 
falciparum growth (Values are mean of three independent 
observations). 
 
CQ sensitivity & 
parasite ID 
 C-PC in g/ml 
 IC50 IC90 IC95 
 Pf-1  8.4 47.9 66.1 
CQ-S Pf-2  13.5 60.3 79.4 
 Pf-3  8.9 52.5 75.9 
 Pf-4  12.0 66.1 79.4 
CQ-R Pf-5  9.6 60.3 75.9 
 Pf-6  9.6 44.7 63.1 
 
The Inhibitory Concentration (IC) is commonly 
used as a measure of antagonist drug potency in 
pharmacological research. The IC50, IC90, and IC95 of 
C-PC were determined constructing a dose-response 
curve. The IC50 is a measure of the effectiveness of C-
PC in inhibiting malaria parasite growth by half. 
The problems of drug resistance in P. falciparum 
are escalating. New drugs of herbal origin discovered 
through ethnopharmacological studies have shown 
interesting results. The present screening of C-PC for in 
vitro antiplasmodial activity against P. falciparum was 
performed with an aim to investigate the activity of the 
compound in order to discover new lead structures or 
improve the traditional medicine and to understand the 
biomedical importance of algal pigments. In this study, 
C-PC was found to be effective against both 
chloroquine-sensitive and chloroquine-resistant even at 
very low concentrations. C-PC used in the present study 
was a~124 kDa, water soluble protein molecule. 
We may postulate that the possible mechanism 
might be the destruction of polymerization of 
haemozoin by binding with ferriprotoporphyrin-IX (FP-
IX). As C-PC is a large protein molecule, so it is unable 
to diffuse directly through the lipid bilayer of plasma 
membrane. One mechanism could be the proteolytic 
cleavage of C-PC molecule and fragmented active 
functional moiety that may traverse through the plasma 
membrane or trans-membrane region linked with 
another carrier protein [22, 23]. 
Due to its nutritive and medicinal properties 
including hepatoprotective property and negligible 
toxicity, C-PC could act as an oral supplement. Thus, it 
may be concluded that C-PC could be used as a safe, 
potent and as an oral supplement along with known 
recommended antimalarial drugs for both CQ-S and 
CQ-R parasites and seem to be crucial in realizing the 
importance and use of algal pigment in the field of 
biomedical sciences. 
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